Published October 23, 2012 by LawsuitInformation.org Manufactured by pharmaceutical giant GlaxoSmithKline, Wellbutrin is an antidepressant drug that has been linked to congenital birth defects. The U.S. Food and Drug Administration…
Read More
In 2010, DePuy recalled two types of hip replacements, the ASR XL Acetabular System and the ASR Hip Resurfacing System. DePuy Orthopaedics is a subsidiary of Johnson & Johnson. DePuy…
Read More
Published October 23, 2012 by LawsuitInformation.org Topamax (topiramate) is an antiepileptic and antiseizure drug used to treat seizures in patients suffering from epilepsy. Topamax is also used to treat people…
Read More
Published May 8, 2012 on TMD A loophole in federal law requires the FDA to approve some previously-recalled medical devices. Now, the agency says it wants to see that changed.…
Read More
It has now come to light that Takeda Pharmaceuticals knew about the cancer risks associated with the ingestion of Actos, a drug they developed to treat type 2 diabetes. However,…
Read More
The first Actos lawsuit has gone to trial in a California Superior Court in Los Angeles, known as Cooper v. Takeda Pharmaceuticals America Inc. Cooper v. Takeda is being heard…
Read More
Published May 7, 2012 on LawsuitInformation.org Settlements for plaintiffs who have experienced serious side effects associated with the popular birth control medications Yaz and Yasmin have reached into the millions,…
Read More
In mid-May 2016, the US Food and Drug Administration (FDA) issued a new safety warning about Levaquin (fluoroquinolone). The regulatory agency warned of serious side effects that could become permanent.…
Read More
In the United Kingdom, the Department of Health and the Medicines and Healthcare Products Regulatory Agency (MHRA) have been collaborating on a safety review of transvaginal mesh. Their collaborative effort…
Read More
Sales are down for testosterone replacement therapy drugs, such as the two most popular testosterone gels, Androgel and Axiron. After a huge spike in 2013 in prescriptions and sales, 2014…
Read More